Orizuru Therapeutics, Inc.
PrivateLast Round
Series B
Feb 29, 2024
Total Funding Raised
$76.62M
Company Overview
Orizuru Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Kyoto. Its latest recorded funding round was a Series B round in February 2024.
Orizuru Therapeutics, Inc. is a biotechnology company that develops regenerative medical products through cell therapy and provides services to support drug discovery research using induced pluripotent stem cell (iPSC) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orizuru Therapeutics, Inc. Comparables
Compare Orizuru Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iPS Bio, Inc. | 82% | |
| Rege Nephro Co., Ltd. | 82% | |
| iHeart Japan Corporation | 79% |
For institutional investors. Book with your work email.
Orizuru Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 29, 2024 | ||||
| Series A | Aug 10, 2021 | ||||
| Seed | Aug 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Orizuru Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Series A |
| 日本ベンチャーキャピタル株式会社 | Series A |
| MUFG Bank | Series B, Series A |
| Japan Growth Capital Investment Corporation | Series B |
| Kyoto University Innovation Capital | Series B, Seed |
| SMBC Venture Capital | Series B, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 29, 2024
$22M round led by Japan Growth Capital Investment Corporation.
- Aug 10, 2021
$55M round with MUFG Bank and SMBC Venture Capital.
For institutional investors. Book with your work email.
Orizuru Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orizuru Therapeutics, Inc.'s valuation, stock price, and market status.
Is Orizuru Therapeutics, Inc. a public or private company?
Orizuru Therapeutics, Inc. is a private company.
What is the current stock price of Orizuru Therapeutics, Inc.?
Orizuru Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Orizuru Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orizuru Therapeutics, Inc. worth (valuation)?
Valuation information for Orizuru Therapeutics, Inc. is not publicly available.
Can I buy Orizuru Therapeutics, Inc. stock?
Orizuru Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orizuru Therapeutics, Inc.'s last funding round?
Orizuru Therapeutics, Inc.'s most recent funding round was Series B on February 29, 2024.
Who are the main investors in Orizuru Therapeutics, Inc.?
Key investors in Orizuru Therapeutics, Inc. include Japan Growth Capital Investment Corporation.
Will Orizuru Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Orizuru Therapeutics, Inc..
How can I track Orizuru Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Orizuru Therapeutics, Inc.'s shares on secondary markets.